|
No. |
Topic |
Place of
Trial |
CTIL
Holder |
| 1. |
A randomised,
double-blind, comparison of three doses of Entercavir vs. Lamivudine
in Immunocompetent subjects with chronic Hepatitis B infection with
viremia on Lamivudine therapy. (Phase III). |
Department of
Medicine Hospital University
59100 Kuala Lumpur. |
Bristol Myers
Squibb (M) Sdn. Bhd. |
| 2. |
A double-blind
placebo-controlled trial to evaluate the efficacy and safety of
Prucalopride tabletws in subjects with chronic constipation. (Phase
III study). |
University of
Malaya Kuala Lumpur. |
Johnson &
Johnson Sdn. Bhd., Selangor. |
| 3. |
An open,
randomised, multicentre, phase II study to evaluate the safety and
therapeutic efficacy of Smithkline Beecham Biologicals
Immunotherapeutics candidate Hepatitis B pharmaccine, administered
together with lamivudine, versus lamivudine alone, in adult patients
with HBeAg positive chronic Hepatitis B. |
- Department of Medicine Hospital
Kuala Lumpur.
- Hospital Selayang
Lebuhraya
Selayang
Kepong, Selangor. |
Smithkline
Beecham
Sdn. Bhd., Selangor. |
| 4. |
A randomized,
experiential double – blind active control study to explore the
effect of a titrated regimen of omapatrilat in Hypertensive Asian
subjects. (Phase III). |
- Department of Medicine Hospital
University
59100 Kuala Lumpur.
- Hospital University Sains
Malaysia
16150 Kubang Kerian
Kelantan |
Bristol Myers
Squibb
(M) Sdn. Bhd.,
Selangor. |
| 5. |
Omapatrilat
Versus Enalapril Randomized Trial of Utility in Reducing Events
(Phase III). |
Department of
Medicine Hospital Universiti
Kuala Lumpur |
Bristol Myers
Squibb (M) Sdn. Bhd., Selangor. |
| 6. |
A phase I study
of Raltitrexed (TomudexTM) during the boost phase of
Radiotherapy in subjects with locally advanced squamous cell
carcinoma (SCC) of the Head and Neck. |
Clinical Oncology
Unit University of Malaya Medical Centre. |
Zeneca Pharma (M)
Kuala Lumpur. |
| 7. |
Phase II
Multi-Centre Study of Caelyx and Cisplatin as primary treatment of
patients with advanced Epitherial Ovarian Cancer. |
Hospital Pulau
Pinang
Pulau Pinang.
University Hospital
Kuala
Lumpur. |
Schering – Plough
Sdn. Bhd. |
| 8. |
Intraconazole
intravenous injectable solution : an expanded access protocol for
the treatment of subjects with a proven systemic fungal infection.
(Phase III) |
Medical
Department
Hospital Kuala Lumpur. |
Johnson &
Johnson Sdn. Bhd.,
Petaling Jaya. |
| 9. |
Randomized,
Triple-blind, Two arm parallel study of the efficacy, tolerability
and safety of losartan 50 mg titrated to Losartan 50
mg/Hydrochlorothiazide 12.5 mg, tritrated to Losartan 100 mg
/Hydrochlorothiazide 25 mg Versus Amlodipine 5 mg titrated to
Amlodipine 10 mg, titrated to Amlodipine 10 mg plus
Hydrochlorothiazide 25 mg in patients with Isolated Systolic
Hypertension. (Phase IV) |
- Jabatan Nefrologi
University Hospital
Kuala Lumpur.
- Jabatan Nefrologi
Hospital Kuala
Lumpur. |
Merck, Sharp
& Dohme (I.A.) Corp.,
Petaling Jaya. |
| 10. |
The early
association of Vapreotide to endoscopic ligation for the control of
acute cirrhotic variceal bleeding and prevention of early
rebleeding. (Phase III) |
Department of
Surgery Faculty of Medicine Hospital University University
Malaya. |
Dr. Chew Yoon
Heng
Hospital University
University Malaya
Kuala
Lumpur. |
